• Amyloid β-Peptide (1-42) (human): Data-Driven Assay Solution

  2026-05-30

  This article delivers a scenario-driven exploration of Amyloid β-Peptide (1-42) (human) (SKU B6057), highlighting its role in reproducible neurotoxicity and cytotoxicity assays. Drawing on peer-reviewed evidence and practical workflow parameters, it guides researchers in optimizing Alzheimer's disease models using this validated reagent.

• Broad-Spectrum Bivalent mRNA Vaccine Neutralizes SARS-CoV-2

  2026-05-29

  Lu et al. developed and evaluated a bivalent mRNA vaccine (RQ3025) that incorporates spike protein mutations prevalent among SARS-CoV-2 variants. Their preclinical results demonstrate that RQ3025 elicits broad, high-titer neutralizing antibody responses and Th1-skewed cellular immunity across several animal models, supporting its potential for future clinical application.

• Demethyleneberberine in NSCLC and Inflammation Research Work

  2026-05-29

  Demethyleneberberine (DMB) empowers translational researchers with a robust, mechanism-driven approach for inflammation and non-small cell lung cancer (NSCLC) models. From cell cycle arrest to pathway-specific modulation, DMB enables reproducible, high-impact experimental designs across disease domains.

• CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce

  2026-05-28

  The CFDA SE Cell Tracer Kit enables stable, covalent fluorescent labeling of cells for long-term tracking in cell proliferation and lineage tracing workflows. It is best suited for in vitro and in vivo applications requiring persistent cell identification, but not for reversible or short-term tracking. Researchers should avoid using this kit for dynamic physiological monitoring or applications requiring rapid dye clearance.

• Baicalein: Applied Protocols for Cancer and Inflammation Res

  2026-05-28

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) enables targeted inhibition of the 12-LOX pathway, providing researchers with a robust compound for dissecting cancer and inflammation mechanisms. This guide translates advanced workflows and troubleshooting strategies into practical, reproducible steps, maximizing the translational value of Baicalein in biochemical and pharmacological studies.

• Applied Insights with EdU Flow Cytometry Assay Kits (Cy3)

  2026-05-27

  Unlock next-generation cell proliferation analysis using EdU Flow Cytometry Assay Kits (Cy3), which combine high-sensitivity DNA synthesis detection with denaturation-free, multiplexable workflows. Explore practical protocols, advanced use-cases, and troubleshooting strategies tailored for demanding biomedical research, including cancer proliferation studies and genotoxicity testing.

• BX795: Precision PDK1 Inhibitor for Immune and Cancer Resear

  2026-05-27

  BX795 offers researchers a versatile, ATP-competitive PDK1 inhibitor with proven efficacy in dissecting innate immune signaling and cancer cell growth. Its dual targeting of TBK1 and IKKε enables nuanced exploration of autophagy, interferon responses, and PI3K/Akt/mTOR pathways. Optimized protocols and troubleshooting tips ensure reproducibility across diverse experimental setups.

• Ziprasidone Hydrochloride: Mechanistic Insights and Translat

  2026-05-26

  Explore Ziprasidone Hydrochloride's unique dual role as a second-generation antipsychotic and GOT1 inhibitor. This article delivers in-depth mechanistic analysis, assay strategy, and critical impurity insights, distinguishing ziprasidone hydrochloride's value for advanced neuroscience and oncology research.

• AMPK Inhibits Autophagy Initiation: Revisiting Energy Stress

  2026-05-26

  A recent study overturns the prevailing view of AMPK as a universal autophagy inducer during glucose starvation, demonstrating instead that AMPK suppresses autophagy initiation through inhibition of ULK1. This nuanced mechanistic insight redefines AMPK's dual role in energy stress management, with implications for research on energy metabolism and metabolic disorders.

• Pharmacokinetic Variability of CSBTA in MASH: Tissue Distrib

  2026-05-25

  This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. The findings reveal that pathological status and repeated dosing substantially modulate drug exposure and distribution, with significant implications for preclinical study design and translational strategies in MASH treatment.

• Targeting FGFR2 Fusion in ICC via Heteroduplex Oligonucleoti

  2026-05-25

  This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2 fusion mutations in intrahepatic cholangiocarcinoma (ICC), leveraging LDL receptor-mediated uptake for tumor selectivity. By combining FGFR2 fusion suppression with asparagine depletion, the research demonstrates a novel strategy to overcome resistance mechanisms and enhance therapeutic efficacy in ICC models.

• Açaí Extracts: Cytotoxicity and Enzyme/Transporter Induction

  2026-05-24

  This study offers a rigorous assessment of Euterpe oleracea (açaí) extracts for cytotoxicity and their ability to induce drug-metabolizing enzymes and transporters in human hepatocytes. The findings highlight selective cytotoxic effects of certain extract preparations but minimal risk for modulating key pharmacokinetic pathways, informing risk assessment for botanical-drug interactions.

• Optimizing hESC Differentiation Into Trophoblasts: Protocol

  2026-05-23

  This study systematically compares four protocols for differentiating human embryonic stem cells (hESCs) into trophoblast lineages using BMP4 with or without dual inhibition of Activin/Nodal and FGF2 signaling. The findings highlight protocol-dependent differences in efficiency and marker expression, informing experimental design for placental and early development research.

• Injectable Hemostatic Adhesive with Antibacterial Function f

  2026-05-22

  The referenced study introduces a blue light-crosslinked GelMA/QCS/Ca2+ hemostatic adhesive that simultaneously achieves rapid hemorrhage control and antibacterial protection in non-compressible wounds. Its improved mechanical and antimicrobial properties address major shortcomings of existing dressings, offering strong translational potential in trauma and surgical care.

• ATS-9R: Precision Gene Silencing in Adipocytes Explained

  2026-05-22

  ATS-9R (Adipocyte-targeting sequence-9-arginine) is a transformative tool for targeted gene silencing in white adipose tissue, enabling researchers to model and potentially treat obesity-linked inflammation with high efficiency and minimal toxicity. Its Prohibitin-mediated uptake and nona-arginine-based nucleic acid condensation outperform traditional vectors, streamlining experimental workflows in metabolic research.

15815 records 1/1055 page Next 12345 下5页 Last page